Day: February 16, 2020

Cost-effectiveness of UTI prescribing attracts attention

FEBRUARY 2020 – An economic analysis proving the cost-effectiveness of pharmacists managing uncomplicated urinary tract infections (UTIs) is garnering interest among Canada and abroad. The report, released last July, assessed the budget impact and cost-effectiveness related to the findings of the RxOUTMAP study, funded in part by the Canadian Foundation for Pharmacy. That study showed […]